Using inverse-weighting in cost-effectiveness analysis with censored data
From MaRDI portal
Publication:5424166
DOI10.1191/0962280202sm308razbMath1121.62677OpenAlexW2057830194WikidataQ30760278 ScholiaQ30760278MaRDI QIDQ5424166
Andrew R. Willan, Eric Bingshu Chen, D. Y. Lin, Richard J. Cook
Publication date: 2 November 2007
Published in: Statistical Methods in Medical Research (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1191/0962280202sm308ra
Related Items
Evaluating costs with unmeasured confounding: a sensitivity analysis for the treatment effect ⋮ A multivariate normal regression model for survival data subject to different types of dependent censoring
Cites Work
- On Estimating Medical Cost and Incremental Cost-Effectiveness Ratios with Censored Data
- Testing Equality of Survival Functions of Quality-Adjusted Lifetime
- Estimating Medical Costs from Incomplete Follow-Up Data
- A consistent estimator for the distribution of quality adjusted survival time
- Linear regression analysis of censored medical costs
- Estimating medical costs with censored data
- A regression-based method for estimating mean treatment cost in the presence of right-censoring
- Efficient Estimation of the Distribution of Quality‐Adjusted Survival Time